ZyVersa Therapeutics, Inc. (ZVSA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.25M |
| Enterprise Value | 1.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.38 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.08 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.66 |
| 52-Week Change 3 | -96.77% |
| S&P500 52-Week Change 3 | 25.59% |
| 52 Week High 3 | 186.20 |
| 52 Week Low 3 | 4.44 |
| 50-Day Moving Average 3 | 7.33 |
| 200-Day Moving Average 3 | 24.57 |
Share Statistics
| Avg Vol (3 month) 3 | 419.91k |
| Avg Vol (10 day) 3 | 1.04M |
| Shares Outstanding 5 | 759.49k |
| Implied Shares Outstanding 6 | 759.49k |
| Float 8 | 749.61k |
| % Held by Insiders 1 | 0.83% |
| % Held by Institutions 1 | 2.65% |
| Shares Short (Apr 15, 2024) 4 | 46.08k |
| Short Ratio (Apr 15, 2024) 4 | 0.66 |
| Short % of Float (Apr 15, 2024) 4 | 6.08% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 6.07% |
| Shares Short (prior month Mar 15, 2024) 4 | 64.6k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Apr 26, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -12.82% |
| Return on Equity (ttm) | -177.53% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -14.41M |
| Net Income Avi to Common (ttm) | -106.25M |
| Diluted EPS (ttm) | -1,089.70 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.14M |
| Total Cash Per Share (mrq) | 4.13 |
| Total Debt (mrq) | 8.66k |
| Total Debt/Equity (mrq) | 0.08% |
| Current Ratio (mrq) | 0.33 |
| Book Value Per Share (mrq) | 27.33 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8.72M |
| Levered Free Cash Flow (ttm) | -5.46M |
© 2024 Yahoo. All rights reserved.